What are therapeutic peptides?
Therapeutic peptides are biologically active agents derived from naturally occurring peptides or sometimes synthesized by natural peptide as a template. Naturally occurring peptides are influential mediators in many key biological functions in the body, such as regulating blood sugar levels and their unique condition of low toxicity compounds make them attractive candidates for the treatment of the disease. Research has shown that medicines for therapeutic peptides have a high specificity for intended receptors and create significantly lower side effects than traditional treatment approaches. High specificity also reduces the chances of dangerous drug interactions on drugs. Proponents of therapy therapeutic peptide seek to develop a therapeutic peptide "library" from which they can mix and correspond to different peptides to create high -specific pharmacies.er centers and other institutions that employ top scientists. Laboratories and case studies report positive research inFight against solid tumors with therapeutic peptide similar to elastin. Stable, synthetically produced peptides are investigated as a new antimicrobial substance, which is welcome to many clinical general practitioners for whom traditional antibiotics lose their overall efficiency. Newer positive results are partly caused by better administration paths that bring more clinically significant results.
peptides suffer from extremely low biological availability in orally; The digestive process quickly breaks peptide formulations. This leads to rapid degradation and elimination of therapeutic peptides before they can become medically active. For this reason, therapeutic peptides are usually given by injection, Greatly increases their pharmacological effect. They also evolve and test as suitable methods of delivery of nasal and pulmonary applications.
Cancer treatment is at the forefront of the therapeutic peptide. PromptKUM has shown that some peptides are able to penetrate with cancer cells relatively easily. Some peptides also showed the ability to inhibit communication between cancer cell colonies, which reduces their defense. Despite the reported receptive studies, some scientists and doctors are still hesitant to use therapeutic peptides in clinical practice. The main reasons for hesitation include unique systemic side effects, poor passage through the blood -brain barrier with a short half -life in the plasma and limiting the selection on the drug supply route.
A widespread study is performed on the ability of therapeutic peptides to treat breast cancer. Dr. Wei-Zzzen of Wayne State University is in the forefront of research in this area. Its approach focuses on the progression of breast cancer progression by initiating immunotherapy of a recombinant deoxyribonucleic acid (DNA) by a vaccine associated with a cocktail of highly specific therapeutic peptides. Most types of breast tumors excessively express this antigen and therapy has been proven in smallH, but carefully procurable studies that induce anti -tumor immune responses.
A well -known drug that treats visceral fat, which can accumulate in human immunodeficiency virus -positive individuals, tesamorelin, is treatment with food and drug administration (FDA) in the United States and is also approved for use in many European countries. Active chemical tesamorelin is an analog factor releasing growth hormones. This therapeutic peptide increases the release of growth hormone that breaks down greasy tissues and can help build and correct the tissues of organs that have been subject to damage caused by the virus, toxic syndrome of immune deficiency (AIDS), drugs, toxic immune deficiency (AIDS), and other environmental sources.